GeneWell Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Investors
  • 7

GeneWell General Information

Description

Developer of reference standards designed to improve the accuracy of molecular testing. The company's technology utilises real biological samples and paired tumour cell lines to produce oncology reference standards, reproductive health controls, infectious disease standards, inherited disease reference materials, and customized genetic standards, enabling clinical laboratories and diagnostic developers to validate instrument sensitivity and ensure diagnostic consistency across various testing platforms.

Contact Information

Formerly Known As
Jingliang Gene Technology (Shenzhen)
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 2028 Shenyan Road, Tiandong Community, Haishan Subdistrict
  • Yantian District
  • Shenzhen, Guangdong 518000
  • China
+86 0755
Primary Industry
Diagnostic Equipment
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • Number 2028 Shenyan Road, Tiandong Community, Haishan Subdistrict
  • Yantian District
  • Shenzhen, Guangdong 518000
  • China
+86 0755

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GeneWell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series C) 04-Mar-2026 Completed Generating Revenue
3. Early Stage VC (Series B) 19-Oct-2022 Completed Generating Revenue
2. Early Stage VC (Series A) 06-Dec-2019 Completed Generating Revenue
1. Seed Round 30-Sep-2018 Completed Startup
To view GeneWell’s complete valuation and funding history, request access »

GeneWell Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Daoyuan Capital Venture Capital Minority
Green Pine Capital Partners Venture Capital Minority
Huada GreenPine Angel Fund Venture Capital Minority
Longping Bio VC-Backed Company Minority
Yuan Longping High-Tech Agriculture Corporation Minority
You’re viewing 5 of 7 investors. Get the full list »

GeneWell FAQs

  • When was GeneWell founded?

    GeneWell was founded in 2018.

  • Where is GeneWell headquartered?

    GeneWell is headquartered in Shenzhen, China.

  • What industry is GeneWell in?

    GeneWell’s primary industry is Diagnostic Equipment.

  • Is GeneWell a private or public company?

    GeneWell is a Private company.

  • What is GeneWell’s current revenue?

    The current revenue for GeneWell is .

  • Who are GeneWell’s investors?

    Daoyuan Capital, Green Pine Capital Partners, Huada GreenPine Angel Fund, Longping Bio, and Yuan Longping High-Tech Agriculture are 5 of 7 investors who have invested in GeneWell.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process